Genuine Parts Company Declares Regular Quarterly Dividend and Announces Additional 15 Million Share Repurchase Program

GPC Biotech Reports Financial Results For Third Quarter and First Nine Months of 2008

GPC Biotech Schedules Conference Call on November 13th to Discuss Third Quarter 2008 Financial Results

GPC Biotech to Present at Rodman & Renshaw Annual Global Investment Conference in New York

Beacon Equity Issues Technical Trade Alerts on Auto Parts Stores: PBY, AAP, ORLY, AZO, PRTS, GPC

GPC Biotech Presents New Pre-Clinical Data on RGB-286638 Broad-Spectrum Kinase Inhibitor at EORTC-NCI-AACR Meeting

Analyst Reports for Eaton Corporation, The Stanley Works, Genuine Parts Company and Schlumberger Limited

Genuine Parts Company Reports Increased Sales and Earnings for Third Quarter and Nine Months Ended September 30, 2008

Gabelli & Company's 32nd Annual Automotive Aftermarket Symposium

Beacon Equity Issues Technical Trade Alerts on Auto Part Stores Stocks: AZO, ORLY, PBY, AAP, GPC, PRTS

Genuine Parts Company Announces 3rd Quarter 2008 Earnings Release Date and Conference Call

Genuine Parts Company Announces Acquisition of Drago Supply Company

Genuine Parts Company Declares Regular Quarterly Dividend and Announces Agreement to Purchase the Midwestern U.S. Business of ActionEmco

GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2008

GPC Biotech Schedules Conference Call on August 13th to Discuss First Half 2008 Financial Results

GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin

GPC Biotech Reports That Marketing Authorization Application for Satraplatin is to Be Withdrawn

Genuine Parts Company Reports Record Sales and Earnings for the Second Quarter and Six Months Ending June 30, 2008

GPC Biotech To Re-Schedule Annual Shareholders' Meeting

Genuine Parts Company Announces 2nd Quarter 2008 Earnings Release Date and Conference Call

GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial of Satraplatin in Patients with Metastatic Hormone-Refractory Prostate Cancer Previously Treated with Docetaxel

GPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refractory to Taxanes

BeaconEquity.com Issues TraderNotes on Auto Part Stocks: GNAU, LKQX, GPC, SMP, MOD, LEA, ALV, TKS

GPC Biotech to Present at Two Upcoming Conferences: 7th Annual Needham Biotechnology & Medical Technology Conference in New York and Piper Jaffray Europe Conference in London

Data from Satraplatin SPARC Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer Progressing after Initial Chemotherapy Presented at 44th ASCO Annual Meeting

New Data from Several Satraplatin Clinical Trials in Solid Tumors Presented at 44th ASCO Annual Meeting

BeaconEquity.com Issues TraderNotes on Aftermarket Auto Parts Stocks: GNAU, MWWC, GPC, CRV, LKQX, MPAA, QTWW, GNTX

GPC Biotech Announces Data from Several Satraplatin Clinical Trials to be Presented at ASCO Annual Meeting

GPC Biotech Reports Financial Results for First Quarter 2008

GPC Biotech Schedules Conference Call on May 15th to Discuss First Quarter 2008 Financial Results

Genuine Parts Company Declares Regular Quarterly Dividend

Genuine Parts Company Reports First Quarter 2008 Results Sales Increased 3%, EPS Increased 6%

Motion Industries Earns a Premier Supplier Award from Eaton

Genuine Parts Company Announces 1st Quarter 2008 Earnings Release Date and Conference Call